Establishment Labs Holdings (ESTA) Interest Coverage Ratio Growth (1y) (2018 - 2026)
Establishment Labs Holdings (ESTA) Interest Coverage Ratio Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -40.19% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -12.04% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 8.92% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -54.61% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -6.18% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 66.99% |
| 10 | Establishment Labs Holdings | 2.54 Bn | 2.47 Bn | 42.34 Mn | 68.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 68.27% |
| Dec 31, 2025 | 82.71% |
| Sep 30, 2025 | 73.76% |
| Jun 30, 2025 | -31.46% |
| Mar 31, 2025 | -43.58% |
| Dec 31, 2024 | 38.44% |
| Sep 30, 2024 | 56.75% |
| Jun 30, 2024 | 52.44% |
| Mar 31, 2024 | 7.18% |
| Dec 31, 2023 | 14.78% |
| Sep 30, 2023 | -110.97% |
| Jun 30, 2023 | -23.33% |
| Mar 31, 2023 | 10.68% |
| Dec 31, 2022 | -48.56% |
| Sep 30, 2022 | 31.28% |
| Jun 30, 2022 | -49.00% |
| Mar 31, 2022 | -154.73% |
| Dec 31, 2021 | -11.05% |
| Sep 30, 2021 | -339.32% |
| Jun 30, 2021 | 54.28% |